UPDATED -- 09.04.08 @9 AM EDT
~~~~~~~~~~~~
Matt Herper, of Forbes, has linked this post -- offering a well-reasoned dissent -- from my tin-foil-hatted wing-nuttery, below. He is, of course, right. And I told an anonymous commenter (Matt?) so, yesterday. Cool. Heh.And now, just to be complete -- I have put up a new post on this topic.
END UPDATED PORTION
~~~~~~~~~~~~
Perhaps Dick Clark and Co. would like to explain why this study, called VYCTOR, involving Vytorin -- was completed in December 2005 -- but was apparently only logged-in, and made public, at ClinicalTrials.gov (Identifier NCT00738296), two weeks ago -- on August 18, 2008.
This VYCTOR study, begun in April 2005(!), investigated Vytorin's effect on carotid intima-media interphase thickness progression measurements (sounds quite a bit like ENHANCE, no?).A HUGE Hat Tip, to PM -- again! -- for a fabulous find!
Stay-tuned -- As I will likely have more on this, by Tuesday afternoon.
No comments:
Post a Comment